Dr Rajendra Patil – Kolhapur - D Y Patil Medical College Kolhapur of Ambika Pathology Laboratory

• Dr. Rajendra Patil is the founder and chief of Ambika Pathology Laboratory, which has recently been acquired by Metropolis Healthcare for ₹17 crore, marking a significant milestone in the laboratory's growth and expansion.
• Under Dr. Patil's leadership, Ambika Pathology Laboratory has achieved NABL accreditation, ensuring high standards of quality and reliability in diagnostic services.
• The acquisition by Metropolis Healthcare highlights Dr. Patil's strategic vision in positioning Ambika Pathology as a competitive player in the healthcare sector, enhancing its capabilities and reach.
• Dr. Patil has been instrumental in establishing Ambika Pathology as a trusted name in the Kolhapur region, contributing to improved healthcare access for the local community.
• With over 24 years of experience in the medical field, Dr. Patil has served as an Associate Professor at D Y Patil Medical College in Kolhapur, influencing the next generation of healthcare professionals.
• Dr. Patil's commitment to education and mentorship in the medical field has fostered a culture of excellence and innovation among students and colleagues at the medical college.
• The partnership with Metropolis Healthcare is expected to enhance the technological capabilities of Ambika Pathology, allowing for more advanced diagnostic services under Dr. Patil's guidance.
• Dr. Patil's contributions to the field of pathology extend beyond laboratory management; they include active participation in community health initiatives aimed at raising awareness about preventive healthcare.
• Through Ambika Pathology, Dr. Patil has implemented various quality control measures and protocols that have set benchmarks for other laboratories in the region.
• Dr. Patil's leadership has not only focused on operational excellence but also on fostering a patient-centric approach, ensuring that the needs and concerns of patients are prioritized.
• The recent acquisition is a testament to Dr. Patil's entrepreneurial spirit and ability to navigate the complexities of the healthcare market, positioning Ambika Pathology for future growth.
• Dr. Patil has been recognized for their contributions to the field of pathology, earning respect and credibility among peers and healthcare professionals.
• Ambika Pathology's integration into Metropolis Healthcare is expected to create synergies that will enhance service delivery, a vision that Dr. Patil has actively championed.
• Dr. Patil's ongoing commitment to professional development and continuous learning has kept Ambika Pathology at the forefront of advancements in diagnostic technology.
• Through strategic partnerships and collaborations, Dr. Patil has expanded the laboratory's service offerings, ensuring comprehensive care for patients in Kolhapur and surrounding areas.

Professional Experience

Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)

Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.

Official Email: Via Ambika Pathology Laboratory corporate communication desk.

Personal Contact: Not publicly disclosed.

What is Dr Rajendra Patil's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).

How can I contact them?
Through Ambika Pathology Laboratory's official communication channels.

Is this an official profile?
No — independently created using public data.

This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.

Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.

Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.

Affluense AI – Smarter Insights. Stronger Relationships with Affluents.

Last Updated: December 2025 · Published by Affluense AI (affluense.ai)